Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.

Worni M, Akushevich I, Gloor B, Scarborough J, Chino JP, Jacobs DO, Hahn SM, Clary BM, Pietrobon R, Shah A.

Ann Surg Oncol. 2012 Apr;19(4):1316-23. doi: 10.1245/s10434-011-2088-2. Epub 2011 Oct 15.

PMID:
22002799
2.

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.

Pancreas. 2008 Jan;36(1):50-5. doi: 10.1097/MPA.0b013e31812575df.

PMID:
18192881
3.

Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.

Waters JA, Schnelldorfer T, Aguilar-Saavedra JR, Chen JH, Yiannoutsos CT, Lillemoe KD, Farnell MB, Sarr MG, Schmidt CM.

J Am Coll Surg. 2011 Aug;213(2):275-83. doi: 10.1016/j.jamcollsurg.2011.04.003. Epub 2011 May 20.

PMID:
21601488
4.

The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).

McMillan MT, Lewis RS, Drebin JA, Teitelbaum UR, Lee MK, Roses RE, Fraker DL, Vollmer CM.

Cancer. 2016 Feb 15;122(4):521-33. doi: 10.1002/cncr.29803. Epub 2015 Nov 20.

5.

Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.

Swartz MJ, Hsu CC, Pawlik TM, Winter J, Hruban RH, Guler M, Schulick RD, Cameron JL, Laheru DA, Wolfgang CL, Herman JM.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):839-44. doi: 10.1016/j.ijrobp.2009.02.071. Epub 2009 Aug 3.

6.

Clinical results of extended lymphadenectomy and intraoperative radiotherapy for pancreatic adenocarcinoma.

Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Tanizawa Y.

Hepatogastroenterology. 2007 Mar;54(74):564-9.

PMID:
17523323
7.

Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.

Wasif N, Bentrem DJ, Farrell JJ, Ko CY, Hines OJ, Reber HA, Tomlinson JS.

Cancer. 2010 Jul 15;116(14):3369-77. doi: 10.1002/cncr.25070.

8.

Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.

Ceppa EP, Roch AM, Cioffi JL, Sharma N, Easler JJ, DeWitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM.

Surgery. 2015 Oct;158(4):937-44; discussion 944-5. doi: 10.1016/j.surg.2015.06.003. Epub 2015 Jul 11.

PMID:
26173683
9.

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Lévy P, Belghiti J, Ruszniewski P.

Gut. 2002 Nov;51(5):717-22.

10.

Invasive IPMN and MCN: same organ, different outcomes?

Kargozaran H, Vu V, Ray P, Bagaria S, Steen S, Ye X, Gagandeep S.

Ann Surg Oncol. 2011 Feb;18(2):345-51. doi: 10.1245/s10434-010-1309-4. Epub 2010 Aug 31.

PMID:
20809175
11.

A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.

McDade TP, Hill JS, Simons JP, Piperdi B, Ng SC, Zhou Z, Kadish SP, Fitzgerald TJ, Tseng JF.

Cancer. 2010 Jul 1;116(13):3257-66. doi: 10.1002/cncr.25069.

12.

Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.

Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N.

Am J Surg Pathol. 2008 Feb;32(2):243-55. doi: 10.1097/PAS.0b013e3181484f1e.

PMID:
18223327
13.

Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.

Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.

Ann Surg Oncol. 2007 Nov;14(11):3174-80. Epub 2007 Aug 12.

PMID:
17694416
14.

Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy.

Turrini O, Waters JA, Schnelldorfer T, Lillemoe KD, Yiannoutsos CT, Farnell MB, Sarr MG, Schmidt CM.

HPB (Oxford). 2010 Sep;12(7):447-55. doi: 10.1111/j.1477-2574.2010.00196.x.

15.

Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Sueda T.

J Surg Oncol. 2009 Jul 1;100(1):13-8. doi: 10.1002/jso.21290.

PMID:
19384908
16.

Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.

Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB.

Ann Surg Oncol. 2006 Apr;13(4):582-94. Epub 2006 Mar 7.

PMID:
16523362
17.

Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas.

Nakagohri T, Konishi M, Inoue K, Tanizawa Y, Kinoshita T.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1480-3.

PMID:
15362782
18.

Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation.

Lafemina J, Katabi N, Klimstra D, Correa-Gallego C, Gaujoux S, Kingham TP, Dematteo RP, Fong Y, D'Angelica MI, Jarnagin WR, Do RK, Brennan MF, Allen PJ.

Ann Surg Oncol. 2013 Feb;20(2):440-7. doi: 10.1245/s10434-012-2702-y. Epub 2012 Oct 31.

PMID:
23111706
19.

Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.

Fan F, Lai EC, Xie F, Yang JM, Xu F, Kan T, Shen RX, Yang XY, Lau Wan Y, Wu MC.

Hepatogastroenterology. 2010 May-Jun;57(99-100):635-9.

PMID:
20698241

Supplemental Content

Support Center